Unexpected cardiotoxicity in haematological bortezomib treated patients

被引：155
|
作者：
Orciuolo, Enrico [1 ]
Buda, Gabriele
Cecconi, Nadia
Galimberti, Sara
Versari, Daniele
Cervetti, Giulia
Salvetti, Antonio
Petrini, Mario
机构：
[1] Univ Pisa, Dept Oncol Transplant & Adv Med, Sect Haematol, I-56100 Pisa, Italy
[2] Univ Pisa, Dept Internal Med, I-56100 Pisa, Italy
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2007年 / 138卷 / 03期
关键词：
bortezomib; cardiotoxicity; haematological patients;
D O I：
10.1111/j.1365-2141.2007.06659.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：396 / 397
页数：2
相关论文
共 50 条
  • [41] Accurate Risk Factors of Cardiotoxicity in Patients With NSCLC Treated With Osimertinib
    Wu, Lei
    Liu, Ning
    Sun, Meili
    JOURNAL OF THORACIC ONCOLOGY, 2025, 20 (03) : e44 - e45
  • [42] Cardiotoxicity in cancer patients treated with immune-checkpoint inhibitors
    Franco, F. F.
    Garitaonaindia, Y.
    Blanco Clemente, M.
    Torrente, M.
    Calvo de Juan, V.
    Collazo Lorduy, A.
    Gutierrez, L.
    Sanchez, J. C.
    del Alba Baamonde, M. A. Gonzalez
    Royuela, A.
    Visedo, G.
    Gonzalez, S. C.
    Martinez Cutillas, M.
    Traseira Puchol, C.
    Aguado, R.
    Mitroi, C. D.
    Provencio, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S1406 - S1406
  • [43] Incidence and risk of cardiotoxicity in cancer patients treated with targeted therapies
    Santoni, Matteo
    Guerra, Federico
    Conti, Alessandro
    Lucarelli, Alessandra
    Rinaldi, Silvia
    Belvederesi, Laura
    Capucci, Alessandro
    Berardi, Rossana
    CANCER TREATMENT REVIEWS, 2017, 59 : 123 - 131
  • [44] Racial and Ethnic Disparities in Cardiotoxicity in Patients With Cancer Treated With Anthracyclines
    Zhang, Lili
    Song, Justin
    Hanif, Waqas
    Clark, Rachel
    Haroun, Magued
    McNaughton, Caroline
    Slipczuk, Leandro
    Garcia, Mario J.
    Pu, Min
    Gongora, Carlos A.
    Neilan, Tomas G.
    Makower, Della
    Hall, Charles B.
    Chambers, Earle C.
    Rodriguez, Carlos J.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2025, 14 (07):
  • [45] Early Detection and Prediction of Cardiotoxicity in Chemotherapy-Treated Patients
    Sawaya, Heloisa
    Sebag, Igal A.
    Plana, Juan Carlos
    Januzzi, James L.
    Ky, Bonnie
    Cohen, Victor
    Gosavi, Sucheta
    Carver, Joseph R.
    Wiegers, Susan E.
    Martin, Randolph P.
    Picard, Michael H.
    Gerszten, Robert E.
    Halpern, Elkan F.
    Passeri, Jonathan
    Kuter, Irene
    Scherrer-Crosbie, Marielle
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (09): : 1375 - 1380
  • [46] The use of biochemical markers in cardiotoxicity monitoring in patients treated for leukemia
    Horácek, JM
    Pudil, R
    Tichy, M
    Jebavy, L
    Strasová, A
    Praus, R
    Zák, P
    Maly, J
    NEOPLASMA, 2005, 52 (05) : 430 - 434
  • [47] Responding to unexpected events - Patients have to be treated as individuals
    Iwanowska, HM
    BRITISH MEDICAL JOURNAL, 2003, 327 (7422): : 1049 - 1049
  • [48] Bortezomib/dexamethasone/doxorubicin liposomalPoor haematological tolerance: case report
    Reactions Weekly, 2016, 1619 (1) : 49 - 49
  • [49] Cardiotoxicity of Targeted Therapies in Children with Haematological Malignancies and Solid Tumors
    Bangeas, Athanasios
    Tragiannidis, Athanasios
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2023, 23 (15) : 1702 - 1709
  • [50] Drug-Related Cardiotoxicity for the Treatment of Haematological Malignancies in Elderly
    Malato, Alessandra
    Saccullo, Giorgia
    Fazio, Giovanni
    Vergara, Beatrice
    Raso, Simona
    Guarneri, Giovanni Paolo
    Russo, Antonio
    Abbadessa, Vincenzo
    Siragusa, Sergio
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (26) : 2872 - 2879
12345